DNA damage repair and telomere length in normal breast, preneoplastic lesions, and invasive cancer

Christophe M. Raynaud, Juana Hernandez, Frédérique P. Llorca, Paolo Nuciforo, Marie Christine Mathieu, Frederic Commo, Suzette Delaloge, Laure Sabatier, Fabrice André, Jean Charles Soria

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Objectives: Carcinogenesis is a multistep process involving the accumulation of genetic and molecular abnormalities. It has been suggested that there is a relationship between telomere attrition in the early stages of carcinogenesis and activation of the DNA damage response machinery. We explored telomere length modification and damage response pathway activation at 3 steps of breast carcinogenesis. Methods: We carried out a retrospective immunohistochemical analysis of pathway ataxia telangiectasia mutated (p-ATM) (series 1981) and +-H2AX (series 139) levels in normal breast, preneoplastic lesions, and invasive carcinoma. Fluorescent in situ hybridization was used to analyze telomere length at each stage. Results: ATM was activated in 45% of normal tissue samples, 70% of preneoplastic lesions, and 14% of breast carcinomas. The increase in ATM activation, between normal tissues and preneoplasia, was not significant (P =0.095), whereas, ATM repression between preneoplasia and cancer was significant (P = 0.0023). Telomeres in preneoplastic lesions were more frequently shorter than those in normal tissues (P = 0.0116). Finally, telomere lengths were long in 38.9% and very short in 38.9% of breast carcinomas (P = 0.0087 for comparisons with preneoplastic lesions). Conclusions: This study suggests that a major defect in DNA repair occurs between preneoplasia and breast cancer. This defect is associated with changes in telomere length between the preneoplastic and the cancer stage.

Original languageEnglish
Pages (from-to)341-345
Number of pages5
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Volume33
Issue number4
DOIs
Publication statusPublished - 1 Aug 2010
Externally publishedYes

Fingerprint

Telomere
DNA Repair
DNA Damage
Breast
Neoplasms
Carcinogenesis
Breast Neoplasms
Ataxia Telangiectasia
Fluorescence In Situ Hybridization
Molecular Biology
Carcinoma

Keywords

  • Carcinogenesis
  • DNA damage repair
  • Telomeres

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Medicine(all)

Cite this

DNA damage repair and telomere length in normal breast, preneoplastic lesions, and invasive cancer. / Raynaud, Christophe M.; Hernandez, Juana; Llorca, Frédérique P.; Nuciforo, Paolo; Mathieu, Marie Christine; Commo, Frederic; Delaloge, Suzette; Sabatier, Laure; André, Fabrice; Soria, Jean Charles.

In: American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 33, No. 4, 01.08.2010, p. 341-345.

Research output: Contribution to journalArticle

Raynaud, CM, Hernandez, J, Llorca, FP, Nuciforo, P, Mathieu, MC, Commo, F, Delaloge, S, Sabatier, L, André, F & Soria, JC 2010, 'DNA damage repair and telomere length in normal breast, preneoplastic lesions, and invasive cancer', American Journal of Clinical Oncology: Cancer Clinical Trials, vol. 33, no. 4, pp. 341-345. https://doi.org/10.1097/COC.0b013e3181b0c4c2
Raynaud, Christophe M. ; Hernandez, Juana ; Llorca, Frédérique P. ; Nuciforo, Paolo ; Mathieu, Marie Christine ; Commo, Frederic ; Delaloge, Suzette ; Sabatier, Laure ; André, Fabrice ; Soria, Jean Charles. / DNA damage repair and telomere length in normal breast, preneoplastic lesions, and invasive cancer. In: American Journal of Clinical Oncology: Cancer Clinical Trials. 2010 ; Vol. 33, No. 4. pp. 341-345.
@article{121d1180613d4bbea34af83403d14bf8,
title = "DNA damage repair and telomere length in normal breast, preneoplastic lesions, and invasive cancer",
abstract = "Objectives: Carcinogenesis is a multistep process involving the accumulation of genetic and molecular abnormalities. It has been suggested that there is a relationship between telomere attrition in the early stages of carcinogenesis and activation of the DNA damage response machinery. We explored telomere length modification and damage response pathway activation at 3 steps of breast carcinogenesis. Methods: We carried out a retrospective immunohistochemical analysis of pathway ataxia telangiectasia mutated (p-ATM) (series 1981) and +-H2AX (series 139) levels in normal breast, preneoplastic lesions, and invasive carcinoma. Fluorescent in situ hybridization was used to analyze telomere length at each stage. Results: ATM was activated in 45{\%} of normal tissue samples, 70{\%} of preneoplastic lesions, and 14{\%} of breast carcinomas. The increase in ATM activation, between normal tissues and preneoplasia, was not significant (P =0.095), whereas, ATM repression between preneoplasia and cancer was significant (P = 0.0023). Telomeres in preneoplastic lesions were more frequently shorter than those in normal tissues (P = 0.0116). Finally, telomere lengths were long in 38.9{\%} and very short in 38.9{\%} of breast carcinomas (P = 0.0087 for comparisons with preneoplastic lesions). Conclusions: This study suggests that a major defect in DNA repair occurs between preneoplasia and breast cancer. This defect is associated with changes in telomere length between the preneoplastic and the cancer stage.",
keywords = "Carcinogenesis, DNA damage repair, Telomeres",
author = "Raynaud, {Christophe M.} and Juana Hernandez and Llorca, {Fr{\'e}d{\'e}rique P.} and Paolo Nuciforo and Mathieu, {Marie Christine} and Frederic Commo and Suzette Delaloge and Laure Sabatier and Fabrice Andr{\'e} and Soria, {Jean Charles}",
year = "2010",
month = "8",
day = "1",
doi = "10.1097/COC.0b013e3181b0c4c2",
language = "English",
volume = "33",
pages = "341--345",
journal = "American Journal of Clinical Oncology",
issn = "0277-3732",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - DNA damage repair and telomere length in normal breast, preneoplastic lesions, and invasive cancer

AU - Raynaud, Christophe M.

AU - Hernandez, Juana

AU - Llorca, Frédérique P.

AU - Nuciforo, Paolo

AU - Mathieu, Marie Christine

AU - Commo, Frederic

AU - Delaloge, Suzette

AU - Sabatier, Laure

AU - André, Fabrice

AU - Soria, Jean Charles

PY - 2010/8/1

Y1 - 2010/8/1

N2 - Objectives: Carcinogenesis is a multistep process involving the accumulation of genetic and molecular abnormalities. It has been suggested that there is a relationship between telomere attrition in the early stages of carcinogenesis and activation of the DNA damage response machinery. We explored telomere length modification and damage response pathway activation at 3 steps of breast carcinogenesis. Methods: We carried out a retrospective immunohistochemical analysis of pathway ataxia telangiectasia mutated (p-ATM) (series 1981) and +-H2AX (series 139) levels in normal breast, preneoplastic lesions, and invasive carcinoma. Fluorescent in situ hybridization was used to analyze telomere length at each stage. Results: ATM was activated in 45% of normal tissue samples, 70% of preneoplastic lesions, and 14% of breast carcinomas. The increase in ATM activation, between normal tissues and preneoplasia, was not significant (P =0.095), whereas, ATM repression between preneoplasia and cancer was significant (P = 0.0023). Telomeres in preneoplastic lesions were more frequently shorter than those in normal tissues (P = 0.0116). Finally, telomere lengths were long in 38.9% and very short in 38.9% of breast carcinomas (P = 0.0087 for comparisons with preneoplastic lesions). Conclusions: This study suggests that a major defect in DNA repair occurs between preneoplasia and breast cancer. This defect is associated with changes in telomere length between the preneoplastic and the cancer stage.

AB - Objectives: Carcinogenesis is a multistep process involving the accumulation of genetic and molecular abnormalities. It has been suggested that there is a relationship between telomere attrition in the early stages of carcinogenesis and activation of the DNA damage response machinery. We explored telomere length modification and damage response pathway activation at 3 steps of breast carcinogenesis. Methods: We carried out a retrospective immunohistochemical analysis of pathway ataxia telangiectasia mutated (p-ATM) (series 1981) and +-H2AX (series 139) levels in normal breast, preneoplastic lesions, and invasive carcinoma. Fluorescent in situ hybridization was used to analyze telomere length at each stage. Results: ATM was activated in 45% of normal tissue samples, 70% of preneoplastic lesions, and 14% of breast carcinomas. The increase in ATM activation, between normal tissues and preneoplasia, was not significant (P =0.095), whereas, ATM repression between preneoplasia and cancer was significant (P = 0.0023). Telomeres in preneoplastic lesions were more frequently shorter than those in normal tissues (P = 0.0116). Finally, telomere lengths were long in 38.9% and very short in 38.9% of breast carcinomas (P = 0.0087 for comparisons with preneoplastic lesions). Conclusions: This study suggests that a major defect in DNA repair occurs between preneoplasia and breast cancer. This defect is associated with changes in telomere length between the preneoplastic and the cancer stage.

KW - Carcinogenesis

KW - DNA damage repair

KW - Telomeres

UR - http://www.scopus.com/inward/record.url?scp=77956635152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956635152&partnerID=8YFLogxK

U2 - 10.1097/COC.0b013e3181b0c4c2

DO - 10.1097/COC.0b013e3181b0c4c2

M3 - Article

VL - 33

SP - 341

EP - 345

JO - American Journal of Clinical Oncology

JF - American Journal of Clinical Oncology

SN - 0277-3732

IS - 4

ER -